ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 954,48
1,85%
DAX
18 518,03
-0,44%
Brent Oil
83,19
-1,36%
Bitcoin
64 767,30
-0,13%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
31/07/201216h20Dow Jones NewsUPDATE: Cipla April-June Profit Beats Forecast on Sales, Weak RupeeNYSE:TEVATeva Pharmaceutical Industries Ltd.
30/07/201213h06Dow Jones NewsEU Sends Objections on Drug to Servier, Other ManufacturersNYSE:TEVATeva Pharmaceutical Industries Ltd.
26/07/201216h02Dow Jones NewsBristol-Myers Sues Novartis to Block Proposed Generic BaracludeNYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201223h11Dow Jones NewsUS Judge Upholds Claims in Pfizer's Lyrica PatentsNYSE:TEVATeva Pharmaceutical Industries Ltd.
18/07/201215h31PR Newswire (US)Stock Alerts For Berkshire Hathaway, America Movil SAB de CV, EnCana, Teva Pharmaceutical, and Dish Network Released By Inves...NYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/201218h49Business WireTeva to Report Second Quarter 2012 Financial Results on August 2, 2012NYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/201215h21Dow Jones NewsWatson Pharmaceuticals: FDA Approves Generic of Teva's Plan B Emergency ContraceptiveNYSE:TEVATeva Pharmaceutical Industries Ltd
11/07/201212h07Business WireTeva Announces Favorable United Kingdom Court Ruling In COPAXONE® Patent Litigation ProceedingNYSE:TEVATeva Pharmaceutical Industries Ltd
10/07/201215h00PR Newswire (US)OncoGenex Announces Clinical Development Plans for Custirsen in Non-Small Cell Lung CancerNYSE:TEVATeva Pharmaceutical Industries Ltd
02/07/201217h26Edgar (US Regulatory)Report of Foreign Issuer (6-K)NYSE:TEVATeva Pharmaceutical Industries Ltd
29/06/201223h00Business WireTeva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing...NYSE:TEVATeva Pharmaceutical Industries Ltd
27/06/201214h00MarketwiredEquity Research on Allergan Inc. and Teva Pharmaceutical Industries Ltd - Generic Releases and Good Times for Drug Manufactur...NYSE:TEVATeva Pharmaceutical Industries Ltd
27/06/201213h20PR Newswire (US)Teva UK Limited Launches Generic Ibandronic Acid TabletsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/06/201220h24Dow Jones NewsUPDATE: Teva Shares Jump as Court Upholds Patents on MS DrugNYSE:TEVATeva Pharmaceutical Industries Ltd.
25/06/201215h21Dow Jones NewsShire Sinks On Generic Adderall XR Approval But Rebound SeenNYSE:TEVATeva Pharmaceutical Industries Ltd.
25/06/201215h13Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNYSE:TEVATeva Pharmaceutical Industries Ltd.
25/06/201213h20Dow Jones NewsTeva: Court Validates Copaxone Patents; Mylan, Momenta Plan AppealsNYSE:TEVATeva Pharmaceutical Industries Ltd
23/06/201208h28Business WireTeva Announces Favorable Court Ruling in COPAXONE® Patent Infringement LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
22/06/201211h38PR Newswire (US)Teva UK Limited Launches Rivastigmine CapsulesNYSE:TEVATeva Pharmaceutical Industries Ltd
21/06/201219h27Business WireTeva Announces Launch of Generic Symbyax® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
20/06/201215h00MarketwiredEquities Lead Investor Sentiment - Research Report on Sanofi SA (ADR) and Teva Pharmaceutical Industries Ltd (ADR)NYSE:TEVATeva Pharmaceutical Industries Ltd
14/06/201215h02Dow Jones NewsTeva Multiple-Sclerosis Treatment Meets Goals in New Dosing RegimenNYSE:TEVATeva Pharmaceutical Industries Ltd.
14/06/201214h00Business WireTeva Announces Top-Line Results from GALA Phase III Trial Evaluating a New Dosage for Glatiramer Acetate Given Three Times We...NYSE:TEVATeva Pharmaceutical Industries Ltd
14/06/201208h00PR Newswire (US)Now Available: (Oroeze) Benzydamine 0.15% w/v Oromucosal SprayNYSE:TEVATeva Pharmaceutical Industries Ltd
13/06/201217h26Business WireTeva Announces AZILECT® (Rasagiline Tablets) Data to Be Presented at the 16th Annual International Congress of Parkinson’s...NYSE:TEVATeva Pharmaceutical Industries Ltd
11/06/201219h02Dow Jones NewsUPDATE: Forest Labs Cuts View On Impacts of Lexapro Patent ExpiryNYSE:TEVATeva Pharmaceutical Industries Ltd.
08/06/201215h18Dow Jones NewsMylan, Teva Settle Litigation Over Generic ProvigilNYSE:TEVATeva Pharmaceutical Industries Ltd.
07/06/201215h00MarketwiredCalender of Events - Report Highlights Sanofi SA (ADR) and Teva Pharmaceutical Industries Ltd (ADR)NYSE:TEVATeva Pharmaceutical Industries Ltd
05/06/201215h47Business WireTeva to Present at the Jefferies 2012 Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
04/06/201220h38Business WireTeva to Present at the Goldman Sachs 33rd Annual Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
HO
Thales
EU
VIV
Vivendi
EU
BNP
BNP Paribas
NASDAQ
AAPL
Apple
EU
RI
Pernod Ricard
FTSE
UKX
FTSE 100
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
NYSE
JPM
JP Morgan Chase
EU
EN
Bouygues
EU
CS
Axa
EU
LR
Legrand
COIN
ETHUSD
Ethereum
EU
GLE
Societe Generale
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés